TITLE

Detection and quantification of S-100 protein in ocular tissues and fluids from patients with intraocular melanoma

AUTHOR(S)
Cochran, A J; Holland, G N; Saxton, R E; Damato, B E; Foulds, W R; Herschman, H R; Foos, R Y; Straatsma, B R; Lee, W R
PUB. DATE
November 1988
SOURCE
British Journal of Ophthalmology;Nov1988, Vol. 72 Issue 11, p874
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66080803

 

Related Articles

  • Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging? Küker, W.; Herrlinger, U.; Grönewäller, E.; Rohrbach, J. M.; Weller, M. // Journal of Neurology;Dec2002, Vol. 249 Issue 12, p1713 

    Primary ocular lymphoma, which affects the posterior parts of the eye, is an ocular manifestation of primary central nervous system lymphoma (PCNSL). It used to be the ocular disease with the shortest time of survival, even worse than ocular melanoma. Death ensues by CNS dissemination....

  • Cytokines and Chemokines in Uveitis -- Is there a Correlation with Clinical Phenotype? Ooi, Kenneth G.-J.; Galatowicz, Grazyna; Calder, Virginia L.; Lightman, Susan L. // Clinical Medicine & Research;Dec2006, Vol. 4 Issue 4, p294 

    Uveitis is a general term for intraocular inflammation and includes a large number of clinical phenotypes. As a group of disorders, it is responsible for 10% of all registered blind patients under the age of 65 years. Immune-mediated uveitis may be associated with a systemic disease or may be...

  • The impact of selected factors on early diagnosis of multiple primary cancers in patients with uveal melanoma. Mierzwa-Dobranowska, Marzena; Romanowska-Dixon, Bożena // Contemporary Oncology / Wspolczesna Onkologia;2013, Vol. 17 Issue 6, p510 

    Aim of the study: To find differences between a group of patients with intraocular melanoma and another primary cancer and a group of patients with no identifiable second primary cancer. Material and methods: The analysis involved 240 participants, selected from patients who were treated for...

  • Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay. Welinder, Charlotte; Jönsson, Göran B.; Ingvar, Christian; Lundgren, Lotta; Baldetorp, Bo; Olsson, Håkan; Breslin, Thomas; Rezeli, Melinda; Jansson, Bo; Fehniger, Thomas E.; Laurell, Thomas; Wieslander, Elisabet; Pawlowski, Krzysztof; Marko-Varga, György // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Globally, malignant melanoma shows a steady increase in the incidence among cancer diseases. Malignant melanoma represents a cancer type where currently no biomarker or diagnostics is available to identify disease stage, progression of disease or personalized medicine treatment. The aim of this...

  • Subtle signs, symptoms make recognition of ocular malignancies tricky but vital. Bechtel, Bryan // Ocular Surgery News;7/10/2010, Vol. 28 Issue 13, p1 

    The article reports on the need for ophthalmologists to be vigilant of the life-threatening nature of ocular malignancies. According to ocular oncologist Timothy G. Murray, the recognition of an intraocular malignancy or extraocular mass is delayed because such malignancies have relatively...

  • MRI of retinoblastoma. RAZEK, A. A. K. A.; ELKHAMARY, S. // British Journal of Radiology;Sep2011, Vol. 84 Issue 1005, p775 

    We review the role of MRI in retinoblastoma and simulating lesions. Retinoblastoma is the most common paediatric intra-ocular tumour. It may be endophytic, exophytic or a diffuse infiltrating tumour. MRI can detect intra-ocular, extra-ocular and intracranial extension of the tumour. MRI is...

  • Target for treating uveal melanoma.  // Journal of Clinical Pathology;Jul2002, Vol. 55 Issue 7, p553 

    Studies the role of growth factors in eyes in enabling patients with melanoma of the uvea to retain their eyes. Importance of detecting vascular endothelial growth factor-A (VEGF-A) in the ocular fluid of affected eyes in treatments in trial stage for blocking VEGF-A; Detection of the median...

  • The relationship between interleukin 8 and ki67 in cutaneous malignant melanoma. Anghel, Amalia-Elena; Ene, Corina-Daniela; Neagu, Monica; Nicolae, Ilinca // Human & Veterinary Medicine;2015, Vol. 7 Issue 3, p149 

    Background and objectives: Malignant melanoma still represents one of the most aggressive types of cutaneous cancers with a growing incidence all over the world. Interleukin 8 (IL-8) is an extremely valuable molecular marker, involved in oncogenesis and tumor progression. Ki 67 is a well-known...

  • Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis. Sayaka Yamamoto; Sunao Sugita; Yoshiharu Sugamoto; Norio Shimizu; Tomohiro Morio; Manabu Mochizuki // Japanese Journal of Ophthalmology;Nov2008, Vol. 52 Issue 6, p463 

    Abstract Purpose  To measure the genomic DNA from Epstein-Barr virus (EBV) in ocular fluids and to analyze the clinical relevance of EBV in uveitis. Methods  Intraocular fluids (30 aqueous humor and 30 vitreous fluid samples) were taken from 55 patients with uveitis after informed...

  • Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Kimura, Keisuke; Usui, Yoshihiko; Goto, Hiroshi // Japanese Journal of Ophthalmology;Jul2012, Vol. 56 Issue 4, p383 

    Purpose: Intraocular lymphoma is a rare disease with a poor prognosis. Early diagnosis and early treatment greatly influence the survival prognosis of this disease. This retrospective study aimed to clarify the clinical features of patients diagnosed with intraocular lymphoma, and the diagnostic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics